Reduced prevalence of SARS-CoV-2 infection in ABO blood group O

115Citations
Citations of this article
250Readers
Mendeley users who have this article in their library.

Your institution provides access to this article.

Abstract

Identification of risk factors for contracting and developing serious illness following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is of paramount interest. Here, we performed a retrospective cohort analysis of all Danish individuals tested for SARS-CoV-2 between 27 February 2020 and 30 July 2020, with a known ABO and RhD blood group, to determine the influence of common blood groups on virus susceptibility. Distribution of blood groups was compared with data from nontested individuals. Participants (29% of whom were male) included 473 654 individuals tested for SARS-CoV-2 using real-time polymerase chain reaction (7422 positive and 466 232 negative) and 2 204 742 nontested individuals, accounting for ∼38% of the total Danish population. Hospitalization and death from COVID-19, age, cardiovascular comorbidities, and job status were also collected for confirmed infected cases. ABO blood groups varied significantly between patients and the reference group, with only 38.41% (95% confidence interval [CI], 37.30-39.50) of the patients belonging to blood group O compared with 41.70% (95% CI, 41.60-41.80) in the controls, corresponding to a relative risk of 0.87 (95% CI, 0.83-0.91) for acquiring COVID-19. This study identifies ABO blood group as a risk factor for SARS-CoV-2 infection but not for hospitalization or death from COVID-19.

References Powered by Scopus

Presenting Characteristics, Comorbidities, and Outcomes among 5700 Patients Hospitalized with COVID-19 in the New York City Area

6878Citations
N/AReaders
Get full text

Incidence of thrombotic complications in critically ill ICU patients with COVID-19

3499Citations
N/AReaders
Get full text

Genomewide association study of severe covid-19 with respiratory failure

1426Citations
N/AReaders
Get full text

Cited by Powered by Scopus

ABO blood group and COVID-19: a review on behalf of the ISBT COVID-19 Working Group

104Citations
N/AReaders
Get full text

The SARS-CoV-2 receptor-binding domain preferentially recognizes blood group A

72Citations
N/AReaders
Get full text

Predictors of length of hospital stay, mortality, and outcomes among hospitalised COVID-19 patients in Saudi Arabia: A cross-sectional study

68Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Barnkob, M. B., Pottegård, A., Støvring, H., Haunstrup, T. M., Homburg, K., Larsen, R., … Barington, T. (2020). Reduced prevalence of SARS-CoV-2 infection in ABO blood group O. Blood Advances, 4(20), 4990–4993. https://doi.org/10.1182/BLOODADVANCES.2020002657

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 51

47%

Researcher 24

22%

Professor / Associate Prof. 19

18%

Lecturer / Post doc 14

13%

Readers' Discipline

Tooltip

Medicine and Dentistry 55

50%

Biochemistry, Genetics and Molecular Bi... 33

30%

Nursing and Health Professions 12

11%

Agricultural and Biological Sciences 10

9%

Article Metrics

Tooltip
Mentions
News Mentions: 9

Save time finding and organizing research with Mendeley

Sign up for free